South & Central America Genetic Testing Services Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2031

Report Coverage:
  • Service Type (Predictive Testing, Carrier Testing, Prenatal Testing, Newborn Screening, Diagnostic Genetic Testing, Others)
  • Disease (Cancer, Cardiovascular Diseases, Metabolic Diseases, Other Diseases)
  • Service Provider (Hospital-Based Laboratories, Diagnostic Laboratories, Others)

No. of Pages: 186
Report Code: BMIRE00030244
Category: Life Sciences
South & Central America Genetic Testing Services Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. South & Central America Genetic Testing Services Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. South & Central America Genetic Testing Services Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. South & Central America Genetic Testing Services Market Regional Analysis

6.2 South & Central America Genetic Testing Services Market Revenue 2021-2031 (US$ Million)
6.3 South & Central America Genetic Testing Services Market Forecast Analysis

7. South & Central America Genetic Testing Services Market Analysis – by Service Type

7.1 Predictive Testing
  • 7.1.1 Overview
  • 7.1.2 Predictive Testing: South & Central America Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Carrier Testing
  • 7.2.1 Overview
  • 7.2.2 Carrier Testing: South & Central America Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Prenatal Testing
  • 7.3.1 Overview
  • 7.3.2 Prenatal Testing: South & Central America Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Newborn Screening
  • 7.4.1 Overview
  • 7.4.2 Newborn Screening: South & Central America Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Diagnostic Genetic Testing
  • 7.5.1 Overview
  • 7.5.2 Diagnostic Genetic Testing: South & Central America Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.6 Others
  • 7.6.1 Overview
  • 7.6.2 Others: South & Central America Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. South & Central America Genetic Testing Services Market Analysis – by Disease

8.1 Cancer
  • 8.1.1 Overview
  • 8.1.2 Cancer: South & Central America Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Cardiovascular Diseases
  • 8.2.1 Overview
  • 8.2.2 Cardiovascular Diseases: South & Central America Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Metabolic Diseases
  • 8.3.1 Overview
  • 8.3.2 Metabolic Diseases: South & Central America Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Other Diseases
  • 8.4.1 Overview
  • 8.4.2 Other Diseases: South & Central America Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. South & Central America Genetic Testing Services Market Analysis – by Service Provider

9.1 Hospital-Based Laboratories
  • 9.1.1 Overview
  • 9.1.2 Hospital-Based Laboratories: South & Central America Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Diagnostic Laboratories
  • 9.2.1 Overview
  • 9.2.2 Diagnostic Laboratories: South & Central America Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Others
  • 9.3.1 Overview
  • 9.3.2 Others: South & Central America Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

10. South & Central America Genetic Testing Services Market – South and Central America Analysis

10.1 Overview

10.2 South and Central America
  • 10.2.1 South & Central America Genetic Testing Services Market Breakdown, by Key Country, 2024 and 2031 (%)
  • 10.2.1.1 South & Central America Genetic Testing Services Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 Brazil: South & Central America Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.1.1 Brazil: South & Central America Genetic Testing Services Market Breakdown, by Service Type
    • 10.2.1.1.2 Brazil: South & Central America Genetic Testing Services Market Breakdown, by Disease
    • 10.2.1.1.3 Brazil: South & Central America Genetic Testing Services Market Breakdown, by Service Provider
  • 10.2.1.2 Argentina: South & Central America Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.2.1 Argentina: South & Central America Genetic Testing Services Market Breakdown, by Service Type
    • 10.2.1.2.2 Argentina: South & Central America Genetic Testing Services Market Breakdown, by Disease
    • 10.2.1.2.3 Argentina: South & Central America Genetic Testing Services Market Breakdown, by Service Provider
  • 10.2.1.3 South and Central America: South & Central America Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.3.1 South and Central America: South & Central America Genetic Testing Services Market Breakdown, by Service Type
    • 10.2.1.3.2 South and Central America: South & Central America Genetic Testing Services Market Breakdown, by Disease
    • 10.2.1.3.3 South and Central America: South & Central America Genetic Testing Services Market Breakdown, by Service Provider

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Eurofins Scientific SE
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Exact Sciences Corp
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Laboratory Corp of America Holdings
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 23andMe Holding Co
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Ambry Genetics Corp
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Quest Diagnostics Inc
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Illumina Inc
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 F. Hoffmann-La Roche Ltd
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 NeoGenomics Inc
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Centogene NV
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments
13.11 Ancestry Genomics Inc
  • 13.11.1 Key Facts
  • 13.11.2 Business Description
  • 13.11.3 Products and Services
  • 13.11.4 Financial Overview
  • 13.11.5 SWOT Analysis
  • 13.11.6 Key Developments
13.12 Gene By Gene Ltd
  • 13.12.1 Key Facts
  • 13.12.2 Business Description
  • 13.12.3 Products and Services
  • 13.12.4 Financial Overview
  • 13.12.5 SWOT Analysis
  • 13.12.6 Key Developments
13.13 SIVOTEC BioInformatics LLC
  • 13.13.1 Key Facts
  • 13.13.2 Business Description
  • 13.13.3 Products and Services
  • 13.13.4 Financial Overview
  • 13.13.5 SWOT Analysis
  • 13.13.6 Key Developments
13.14 Progenesis
  • 13.14.1 Key Facts
  • 13.14.2 Business Description
  • 13.14.3 Products and Services
  • 13.14.4 Financial Overview
  • 13.14.5 SWOT Analysis
  • 13.14.6 Key Developments
13.15 Fulgent Genetics, Inc
  • 13.15.1 Key Facts
  • 13.15.2 Business Description
  • 13.15.3 Products and Services
  • 13.15.4 Financial Overview
  • 13.15.5 SWOT Analysis
  • 13.15.6 Key Developments
13.16 VERITAS INTERCONTINENTAL
  • 13.16.1 Key Facts
  • 13.16.2 Business Description
  • 13.16.3 Products and Services
  • 13.16.4 Financial Overview
  • 13.16.5 SWOT Analysis
  • 13.16.6 Key Developments
13.17 GeneDx, LLC
  • 13.17.1 Key Facts
  • 13.17.2 Business Description
  • 13.17.3 Products and Services
  • 13.17.4 Financial Overview
  • 13.17.5 SWOT Analysis
  • 13.17.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - South & Central America Genetic Testing Services Market

  • Eurofins Scientific SE
  • Exact Sciences Corp
  • Laboratory Corp of America Holdings
  • 23andMe Holding Co
  • Ambry Genetics Corp
  • Quest Diagnostics Inc
  • Illumina Inc
  • F. Hoffmann-La Roche Ltd
  • NeoGenomics Inc
  • Centogene NV
  • Ancestry Genomics Inc
  • Gene By Gene Ltd
  • SIVOTEC BioInformatics LLC
  • Progenesis
  • Fulgent Genetics, Inc
  • VERITAS INTERCONTINENTAL
  • GeneDx, LLC
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)